Nilsson O R, Karlberg B E, Ohlsson O, Thulin T, Tolagen K
Acta Med Scand. 1979;206(4):303-8.
The antihypertensive effect on the selective beta-1-adrenoceptor blocking agent, atenolol, given in doses of 100 and 200 mg once daily, was evaluated in 37 patients with primary hypertension. The drug induced an efficient reduction of BP, and in the whole patient series there was no difference in BP on either dosage. Exercise tests, performed in 10 patients, showed the same degree of partial beta-blockade 24 hours after intake of 100 and 200 mg atenolol. PRA decreased during treatment with atenolol but there was no correlation between the stimulated pretreatment renin level and the antihypertensive effect of atenolol. Side-effects were few and 35 out of 37 patients continued on atenolol treatment. Central nervous side-effects were not seen.
对37例原发性高血压患者评估了每日一次服用剂量为100毫克和200毫克的选择性β-1肾上腺素能阻滞剂阿替洛尔的降压效果。该药可有效降低血压,在整个患者系列中,两种剂量的血压降低情况无差异。对10例患者进行的运动试验表明,服用100毫克和200毫克阿替洛尔24小时后,部分β受体阻滞程度相同。阿替洛尔治疗期间血浆肾素活性(PRA)降低,但治疗前刺激后的肾素水平与阿替洛尔的降压效果之间无相关性。副作用很少,37例患者中有35例继续接受阿替洛尔治疗。未观察到中枢神经系统副作用。